Researchers found 5.8 percent of outborn neonates were colonized with MRSA upon admission to a NICU, while only 0.2 percent of inborn neonates were colonized with MRSA upon admission.
Researchers suggest the heightened rate of MRSA in outborns may result from outborns being older when transferred into a NICU, so they have been exposed to healthcare facilities for a longer time before admission, according to a Medscape article discussing the study.
Early MRSA detection is “critical” to decreasing acquisition and infection rates, researchers said.
More Articles on Healthcare-Associated Infections:
C. diff Model Predicts Patients at Risk for Recurrence
100 Infection Control Products to Know
Physicians Update MRSA Abscess Treatment Guidelines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
